Please login to the form below

Not currently logged in
Email:
Password:

Eli Lilly buys drug patch for $35m

Eli Lilly & Co has announced that it will buy an osteoporosis drug patch from Israeli company TransPharma Medical
Eli Lilly & Co has announced that it will buy an osteoporosis drug patch from Israeli company TransPharma Medical.

The drug contains a hormone that stimulates new bone growth. It is designed to be administered with a special device that creates tiny pores in the skin just prior to applying the patch.

Under the terms of the deal, should the patch gain approval, TransPharma will be eligible for milestone payments.

13th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics